Regulatory network involving miRNAs and genes in serous ovarian carcinoma.

about

Regulatory network involving miRNAs and genes in serous ovarian carcinoma.

Item

http://www.wikidata.org/entity/Q45874094

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Regulatory network involving miRNAs and genes in serous ovarian carcinoma.

@en

Regulatory network involving miRNAs and genes in serous ovarian carcinoma.

@nl

type

Item

label

Regulatory network involving miRNAs and genes in serous ovarian carcinoma.

@en

Regulatory network involving miRNAs and genes in serous ovarian carcinoma.

@nl

prefLabel

Regulatory network involving miRNAs and genes in serous ovarian carcinoma.

@en

Regulatory network involving miRNAs and genes in serous ovarian carcinoma.

@nl

P1476

Regulatory network involving miRNAs and genes in serous ovarian carcinoma.

@en

P2093

Haiyan Zhao

http://www.w3.org/2001/XMLSchema#string

Hao Xu

http://www.w3.org/2001/XMLSchema#string

Luchen Xue

http://www.w3.org/2001/XMLSchema#string

P2860

Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes

TRANSFAC: a database on transcription factors and their DNA binding sites

Identification of mammalian microRNA host genes and transcription units

miRBase: integrating microRNA annotation and deep-sequencing data

The UCSC Genome Browser database: update 2011

Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers

miR2Disease: a manually curated database for microRNA deregulation in human disease

miRecords: an integrated resource for microRNA-target interactions

P-Match: transcription factor binding site search by combining patterns and weight matrices.

LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin.

P304

6259-6268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.6927

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29113276

http://www.w3.org/2001/XMLSchema#string

P932

5661420

http://www.w3.org/2001/XMLSchema#string